1/63
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
what are clinical manifestations of ACS
sudden chest pain unrelieved by rest and nitroglycerin, shortness of breath, N/V, lightheadedness, sweating, increased or decreased HR & BP and increased RR
in what patients do ACS symptoms vary such as having atypical or silent sx
women, elderly, and diabetics
for PQRST in ACS = P - precipitating factors and palliative measures -> ??
· Typically occurs at rest and not always relieved by rest or SL NTG
for PQRST in ACS = Q - quality of pain -> ??
· Heavy, squeezing, crushing, or burning (may be mistaken as indigestion)
for PQRST in ACS = R - region of pain and radiation of pain -> ??
· Substernal region; radiates to arms, abdomen, back, lower jaw, and neck
for PQRST in ACS = S - severity of pain -> ??
· Worst pain ever experienced - more severe than angina (8-10/10)
for PQRST in ACS = T - temporal pain -> ??
· Lasts > 20 minutes (longer than angina) and is more frequent
when presenting with signs and sx of ACS how fast should immediate assessment happen
within 10 minutes
what labs and tests should be initially run when presenting with signs and sx of ACS
EKG within 10 minutes, cardiac enzyme lab, electrolytes (K or Mg), CBC, lipids, BUN/SCr, glucose, coags, chest x-ray
how many cardiac enzymes should occur over first 12-24 hours
3-4: one at sx onset or presentation to ED and one 3-6 hours after admission and additional measurements q6h to ensure trending down if elevated
is one negative troponin level enough to clear someone of MI
no, get 2nd and if that is negative then we feel better...if catch MI really early, don't have time to see troponin elevation
what is emergent care that should be taking place when someone presents with signs and symptoms of ACS
-IV access
-Continuous cardiac monitoring
-ASA (chewable tablets STAT)
-NTG (can take as many SL as tolerated)
-Oxygen if O2 sats < 90%
when present with ACS what is mnemonic for initial acute supportive care
MONA-B
what is goal of TIMI score with STEMI reperfusion
TIMI 3 flow = complete reperfusion
for STEMI, what treatment approach is preferred and how quickly
primary PCI with or without stenting within 90 minutes
if cannot reach PCI location within ________ minutes, what should be done and how quickly
within 120 minutes...fibrinolysis within 30 minutes
what are the two branches of NSTEMI treatment approach
ischemia guided management (conservative - only PCT) and invasive (PCI) approach
do STEMI or NSTEMI get risk assessment
only NSTEMI
based on what TIMI score do NSTEMI patients get early invasive approach
medium (3-4 pts) and high risk (5-7 pts)
what are pts with TIMI risk score assessment
age ≥ 65, 3 risk factors for CAD (hypercholesterolemia, HTN, DM, smoker, family history of premature CHD), known CAD, use of ASA within past 7 days, ST segment depression, ≥ 2 episodes of chest discomfort in past 24 hours, positive cardiac enzymes
what do low risk (0-2 pts) TIMI risk score patients get
ischemia guided approach
symptom control (MONA-B) should ideally be done within what time frame??
within 30 minutes
what is the M of MONA-B
morphine
what is the general MOA of morphine
arterial and venous vasodilation
what are AE of morphine
hypotension, respiratory depression, N/V, constipation
is morphine a class I recommendation for NSTEMI?
no (it is for STEMI still due to chest pain severity)
what does the O in MONA-B stand for
oxygen
when should ACS patients receive oxygen
if O2 sats < 90% (maintain > 90%)
what is the N in MONA-B
nitroglycerin
who should receive IV NTG
hypertensive patients (especially if hypertensive crisis), HF, ongoing ischemia, refractory angina
what are AE of NTG
hypotension, tachycardia, HA/flushing, tolerance
what are contraindications for NTG
PDE-5 inhibitor, hypotension - SBP < 90mmHg
if using PDE-5 inhibitor for pulmonary HTN (dosed not prn) what should we do about giving NTG
don't give NTG try something else
what is the A in MONA-B
aspirin/antiplatelet
what is the LD of aspirin (MONA-B)
chew 81mg tablet x4
what is the maintenance dose of aspirin (MONA-B)
81-162mg/day indefinitely
what are AE of aspirin
GI upset and bleeding
what are contraindications to aspirin
aspirin allergy (use clopidogrel) and active bleeding
what does the B stand for in MONA-B
beta blocker
what beta blocker should be used in MONA-B
metoprolol (prefer PO over IV)
what are contraindications for metoprolol use in MONA-B
bronchospastic disease, high degree heart block, symptomatic bradycardia (<60bpm), hypotension (SBP < 90), risk factors for cardiogenic shock
what is monitoring for metoprolol in MONA-B
goal HR of 50-60bpm and monitor BP
what is another agent that could be used outside of MONA-B
non-dCCB if contraindication to beta blocker (diltiazem and verapamil) except if HF
these may be indicated in STEMI patients who present within 12 hours of sx onset and if primary PCI cannot be performed within 120 minutes
fibrinolytics
fibrinolytics for STEMI are contraindicated with what risk??
high bleeding risk
in patient > 75 years, do we always use fibrinolytics
not always, have risk/benefit convo with patient and family
what is general MOA of fibrinolytics
will cause clot dissolution and restoration of blood flow to ischemic tissues
what are important absolute contraindications for fibrinolytics
any prior ICH
known malignant intracranial neoplasm
ischemic stroke within 3 months
suspected aortic dissection
active bleeding or bleeding predisposition (diathesis)
what are relative contraindications to fibrinolytics
BP > 180/100 on presentation
current anticoagulant use in therapeutic dose
pregnancy
recent internal bleeding
T/F: Alteplase, reteplase, Tenecteplase are all comparable in usage for STEMI (Tenecteplase has the highest fibrin specificity of the three)
true
what should be monitored with fibrinolytics
· EKG
· BP
· Sites of bleeding
· CBC
· Mental status q2h
· Need baseline aPTT and INR
what are some advantages of fibrinolysis vs PCI for STEMI
· More universal access
· Short time to treatment
· Results less dependent on physician experience
· Lower system costs
what are disadvantages of fibrinolytics vs PCI
· ICH and major bleeding are most serious side effects -Risk factors included older age and uncontrolled HTN
· No TIMI-3 flow in 30-50% of patients - Even with TIMI-3 flow, abnormal reperfusion in 16-30% of patients
what do we need alongside fibrinolytics
dual anti platelet therapy and one anticoagulant
what are antiplatelet options for combo with fibrinolysis
ASA 81mgx4 LD then 81mg/day indefinitely
clopidogrel/plavix
what is dosing for clopidogrel used with fibrinolytics
LD of 300mg + maintenance dose of 75mg
when would we not give 300mg LD of clopidogrel in fibrinolysis
if > 75 years
T/F: clopidogrel is the ONLY P2Y12 that can be used for fibrinolysis due to lowest bleeding risk in the class
true
what are anticoagulant options for use alongside fibrinolytics
UFH x 4h (60u/kg with max of 4000u + 12u/kg/hr with max of 1000u/hr)
LMWH x8 days or until d/c
Enoxaparin
Fondaparinux
what is dosing of enoxparin when used with fibrinolytics? what about if CrCl < 30mL/min
1mg/kg BID; 1mg/kg QD
what is dosing of fondaparinux if used with fibrinolytics
2.5mg QD x 8days or until d/c
when is invasive strategy for STEMI (PCI) preferred
o Skilled PCI lab available (get to ED within 120 minutes, get to cath lab from door within 90 minutes)
o High risk for STEMI (shock)
o Contraindications to fibrinolytic (such as ICH history)
o Dx of STEMI in doubt
when is fibrinolysis for STEMI preferred
o If invasive strategy not an option
Delay to invasive strategy (cannot get there within 120 minutes)